Sporadic hemangioblastomas are characterized by cryptic VHL inactivation
dc.contributor.author | Shankar, Ganesh M | |
dc.contributor.author | Taylor-Weiner, Amaro | |
dc.contributor.author | Lelic, Nina | |
dc.contributor.author | Jones, Robert T | |
dc.contributor.author | Kim, James C | |
dc.contributor.author | Francis, Joshua M | |
dc.contributor.author | Abedalthagafi, Malak | |
dc.contributor.author | Borges, Lawrence F | |
dc.contributor.author | Coumans, Jean-Valery | |
dc.contributor.author | Curry, William T | |
dc.contributor.author | Nahed, Brian V | |
dc.contributor.author | Shin, John H | |
dc.contributor.author | Paek, Sun H | |
dc.contributor.author | Park, Sung-Hye | |
dc.contributor.author | Stewart, Chip | |
dc.contributor.author | Lawrence, Michael S | |
dc.contributor.author | Cibulskis, Kristian | |
dc.contributor.author | Thorner, Aaron R | |
dc.contributor.author | Van Hummelen, Paul | |
dc.contributor.author | Stemmer-Rachamimov, Anat O | |
dc.contributor.author | Batchelor, Tracy T | |
dc.contributor.author | Carter, Scott L | |
dc.contributor.author | Hoang, Mai P | |
dc.contributor.author | Santagata, Sandro | |
dc.contributor.author | Louis, David N | |
dc.contributor.author | Barker, Fred G | |
dc.contributor.author | Meyerson, Matthew | |
dc.contributor.author | Getz, Gad | |
dc.contributor.author | Brastianos, Priscilla K | |
dc.contributor.author | Cahill, Daniel P | |
dc.date.accessioned | 2015-01-16T19:02:16Z | |
dc.date.available | 2015-01-16T19:02:16Z | |
dc.date.issued | 2014-12-24 | |
dc.identifier.citation | Acta Neuropathologica Communications. 2014 Dec 24;2(1):2 | |
dc.identifier.uri | https://hdl.handle.net/2027.42/110224 | en_US |
dc.description.abstract | Abstract Hemangioblastomas consist of 10-20% neoplastic “stromal” cells within a vascular tumor cell mass of reactive pericytes, endothelium and lymphocytes. Familial cases of central nervous system hemangioblastoma uniformly result from mutations in the Von Hippel-Lindau (VHL) gene. In contrast, inactivation of VHL has been previously observed in only a minority of sporadic hemangioblastomas, suggesting an alternative genetic etiology. We performed deep-coverage DNA sequencing on 32 sporadic hemangioblastomas (whole exome discovery cohort n = 10, validation n = 22), followed by analysis of clonality, copy number alteration, and somatic mutation. We identified somatic mutation, loss of heterozygosity and/or deletion of VHL in 8 of 10 discovery cohort tumors. VHL inactivating events were ultimately detected in 78% (25/32) of cases. No other gene was significantly mutated. Overall, deep-coverage sequence analysis techniques uncovered VHL alterations within the neoplastic fraction of these tumors at higher frequencies than previously reported. Our findings support the central role of VHL inactivation in the molecular pathogenesis of both familial and sporadic hemangioblastomas. | |
dc.title | Sporadic hemangioblastomas are characterized by cryptic VHL inactivation | |
dc.type | Article | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/110224/1/40478_2014_Article_167.pdf | |
dc.identifier.doi | 10.1186/s40478-014-0167-x | en_US |
dc.language.rfc3066 | en | |
dc.rights.holder | Shankar et al.; licensee BioMed Central. | |
dc.date.updated | 2015-01-16T19:02:16Z | |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.